A Stem-Cell-Based Drug Gets Approval in Canada

Photo - Prochymal - osiris.com

submitted by Luis Kun

The New York Times - by Andrew Pollack - May 17, 2012

In a boost for the field of regenerative medicine, a small biotechnology company has received regulatory approval in Canada for what it says is the first manufactured drug based on stem cells.

The company, Osiris Therapeutics of Columbia, Md., said Thursday that Canadian regulators had approved its drug Prochymal, to treat children suffering from graft-versus-host disease, a potentially deadly complication of bone marrow transplantation.

“It’s really a good day for the concept and the hope behind stem cell therapies becoming a reality,” C. Randal Mills, the chief executive of Osiris, said in an interview.

(READ COMPLETE ARTICLE)

Osiris - Prochymal - http://www.osiris.com/therapeutics.php#